2004•Shanxi yiyao zazhiRequires access

Measurement of subsets of blood T lymphocyte in patients with severe acute respiratory syndrome and its clinical significance

Zhengyin Wang

Open publisher page 0 citations

Abstract

Objective To investigate the changes of subsets of blood T lymphocyte in patients with severe acute respiratory syndrome (SARS) and their clinical significance.Methods Subsets of blood T lymphocyte in SARS patients were detected by immunocytochemistry.The patient comprised 31 men and 29 women,aged 18~68 years (average 36.1 years).The results detected in 62 normal subjects served as controls.Results The numbers of CD3 +,CD4 + lymphocytes all significantly decreased in acute phase of SARS patients compared with those in nomal subjects.As the patients′ condition improved,the counts of CD3 +,CD4 + gradually returned to normal.In acute phase,the numbers of CD3 +,CD4 + and CD8 + in SARS patients receiving glucocorticoids showed no significant difference from those in SARS patients not receiving glucocorticoids.In recovery phase the numbers of CD3 +,CD4 + and CD8 + in SARS patients receiving thymopolypeptides showed also no significant difference from those in SARS patients not receiving thymopolypeptides.Conclusion In acute phase the SARS patients were found having their cellular immunity damaged,using glucocorticoids or thymopolypeptides hardly can give effect on the cellular immunity in a short time.

About this research paper

What this paper is about

Objective To investigate the changes of subsets of blood T lymphocyte in patients with severe acute respiratory syndrome (SARS) and their clinical significance.Methods Subsets of blood T lymphocyte in SARS patients were detected by immunocytochemistry.The patient comprised 31 men and 29 women,aged 18~68 years (average 36.1 years).The results detected in 62 normal subjects served as controls.Results The numbers of CD3 +,CD4 + lymphocytes all significantly decreased in acute phase of SARS patients compared with those in nomal subjects.As the patients′ condition improved,the counts of CD3 +,CD4 + gradually returned to normal.In acute phase,the numbers of CD3 +,CD4 + and CD8 + in SARS patients receiving glucocorticoids showed no significant difference from those in SARS patients not receiving glucocorticoids.In recovery phase the numbers of CD3 +,CD4 + and CD8 + in SARS patients receiving thymopolypeptides showed also no significant difference from those in SARS patients not receiving thymopolypeptides.Conclusion In acute phase the SARS patients were found having their cellular immunity damaged,using glucocorticoids or thymopolypeptides hardly can give effect on the cellular immunity in a short time.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the changes of subsets of blood T lymphocyte in patients with severe acute respiratory syndrome (SARS) and their clinical significance.Methods Subsets of blood T lymphocyte in SARS patients were detected by immunocytochemistry.The patient comprised 31 men and 29 women,aged 18~68 years (average 36.1 years).The results detected in 62 normal subjects served as controls.Results The numbers of CD3 +,CD4 + lymphocytes all significantly decreased in acute phase of SARS patients compared with those in nomal subjects.As the patients′ condition improved,the counts of CD3 +,CD4 + gradually returned to normal.In acute phase,the numbers of CD3 +,CD4 + and CD8 + in SARS patients receiving glucocorticoids showed no significant difference from those in SARS patients not receiving glucocorticoids.In recovery phase the numbers of CD3 +,CD4 + and CD8 + in SARS patients receiving thymopolypeptides showed also no significant difference from those in SARS patients not receiving thymopolypeptides.Conclusion In acute phase the SARS patients were found having their cellular immunity damaged,using glucocorticoids or thymopolypeptides hardly can give effect on the cellular immunity in a short time.

Key concepts: Medicine, Cellular immunity, Severe acute respiratory syndrome, CD8, CD3, Lymphocyte subsets, Lymphocyte, Respiratory system

Related papers

Back to paper searchBrowse research topicsOriginal source
Measurement of subsets of blood T lymphocyte in patients with severe acute respiratory syndrome and its clinical significance — Research Paper | ScholarLens